메뉴 건너뛰기




Volumn 13, Issue 4, 2007, Pages 226-228

Association of polymorphisms of FAS-1377, FAS-670, and FASL-844 genes with risk factors for cutaneous malignant melanoma

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; FAS ANTIGEN; FAS LIGAND; FASLG PROTEIN, HUMAN; UNCLASSIFIED DRUG;

EID: 35748942608     PISSN: 15289117     EISSN: 1540336X     Source Type: Journal    
DOI: 10.1097/PPO.0b013e31813fffdd     Document Type: Note
Times cited : (2)

References (19)
  • 1
    • 35748938818 scopus 로고    scopus 로고
    • Importance of FAS-1377, FAS-670, and FASL-844 polymorphisms in tumor onset, progression, and pigment phenotypes of Swedish patients with melanoma: A case-control analysis
    • Zhang H, Sun X-F, Synnerstad I, et al. Importance of FAS-1377, FAS-670, and FASL-844 polymorphisms in tumor onset, progression, and pigment phenotypes of Swedish patients with melanoma: a case-control analysis. Cancer J. 2007;13:233-237.
    • (2007) Cancer J , vol.13 , pp. 233-237
    • Zhang, H.1    Sun, X.-F.2    Synnerstad, I.3
  • 2
    • 25144462470 scopus 로고    scopus 로고
    • Genetic polymorphisms of FAS and FASL (CD95/CD95L) genes in cervical carcinogenesis: An analysis of haplotype and gene-gene interaction
    • Lai HC, Lin WY, Lin YW, et al. Genetic polymorphisms of FAS and FASL (CD95/CD95L) genes in cervical carcinogenesis: an analysis of haplotype and gene-gene interaction. Gynecol Oncol. 2005;99:113-118.
    • (2005) Gynecol Oncol , vol.99 , pp. 113-118
    • Lai, H.C.1    Lin, W.Y.2    Lin, Y.W.3
  • 3
    • 20544473024 scopus 로고    scopus 로고
    • Functional polymorphisms in cell death pathway genes FAS and FASL contribute to risk of lung cancer
    • Zhang X, Miao X, Sun T, et al. Functional polymorphisms in cell death pathway genes FAS and FASL contribute to risk of lung cancer. J Med Genet. 2005;2:479-484.
    • (2005) J Med Genet , vol.2 , pp. 479-484
    • Zhang, X.1    Miao, X.2    Sun, T.3
  • 4
    • 34447100140 scopus 로고    scopus 로고
    • Functional polymorphisms in FAS and FASL contribute to increased apoptosis of tumor infiltration lymphocytes and risk of breast cancer
    • Zhang B, Sun T, Xue L, et al. Functional polymorphisms in FAS and FASL contribute to increased apoptosis of tumor infiltration lymphocytes and risk of breast cancer. Carcinogenesis 2007;28:1067-1063.
    • (2007) Carcinogenesis , vol.28 , pp. 1067-1063
    • Zhang, B.1    Sun, T.2    Xue, L.3
  • 5
    • 3242670028 scopus 로고    scopus 로고
    • Polymorphisms of death pathway genes FAS and FASL in esophageal squamous-cell carcinoma
    • Jul 7;
    • Sun T, Miao X, Zhang X, et al. Polymorphisms of death pathway genes FAS and FASL in esophageal squamous-cell carcinoma. J Natl Cancer Inst. 2004 Jul 7;96:1030-1036.
    • (2004) J Natl Cancer Inst , vol.96 , pp. 1030-1036
    • Sun, T.1    Miao, X.2    Zhang, X.3
  • 6
    • 23844487130 scopus 로고    scopus 로고
    • Genetic polymorphisms of apop-tosis-associated genes FAS and FASL and risk of colorectal cancer
    • in Chinese
    • Yang S, Miao XP, Zhang XM, et al. Genetic polymorphisms of apop-tosis-associated genes FAS and FASL and risk of colorectal cancer. Zhonghua Yi Xue Za Zhi. 2005;85:2132-2135 (in Chinese).
    • (2005) Zhonghua Yi Xue Za Zhi , vol.85 , pp. 2132-2135
    • Yang, S.1    Miao, X.P.2    Zhang, X.M.3
  • 7
    • 33744956175 scopus 로고    scopus 로고
    • ING3 promotes UV-induced apoptosis via Fas/ caspase-8 pathway in melanoma cells
    • Elyassaki W, Wu S. ING3 promotes UV-induced apoptosis via Fas/ caspase-8 pathway in melanoma cells. J Biol Chem. 2006;281:11887-11893.
    • (2006) J Biol Chem , vol.281 , pp. 11887-11893
    • Elyassaki, W.1    Wu, S.2
  • 8
    • 0034660614 scopus 로고    scopus 로고
    • p38 protects human melanoma cells from UV-induced apoptosis through down-regulation of NF-κB activity and Fas expression
    • Ivanov VN, Ronai Z. p38 protects human melanoma cells from UV-induced apoptosis through down-regulation of NF-κB activity and Fas expression. Oncogene. 2000;19:3003-3012.
    • (2000) Oncogene , vol.19 , pp. 3003-3012
    • Ivanov, V.N.1    Ronai, Z.2
  • 9
    • 0036052722 scopus 로고    scopus 로고
    • Evaluation of soluble Fas ligand as a serological marker for melanoma
    • Melzani G, Bugari G, Parrinello G, et al. Evaluation of soluble Fas ligand as a serological marker for melanoma. Dermatology. 2002;205: 111-115.
    • (2002) Dermatology , vol.205 , pp. 111-115
    • Melzani, G.1    Bugari, G.2    Parrinello, G.3
  • 10
    • 33748573355 scopus 로고    scopus 로고
    • Expression of Fas ligand (CD95L) in primary malignant melanoma and melanoma metastases is associated with overall survival
    • Neuber K. Eidam B. Expression of Fas ligand (CD95L) in primary malignant melanoma and melanoma metastases is associated with overall survival. Onkologie. 2006;29:361-365.
    • (2006) Onkologie , vol.29 , pp. 361-365
    • Neuber, K.1    Eidam, B.2
  • 11
    • 33645074700 scopus 로고    scopus 로고
    • Polymorphisms of the FAS and FAS ligand genes associated with risk of cutaneous malignant melanoma
    • Li C, Larson D, Zhang Z, Liu Z, et al. Polymorphisms of the FAS and FAS ligand genes associated with risk of cutaneous malignant melanoma. Pharmacogenet Genomics. 2006;16:253-263.
    • (2006) Pharmacogenet Genomics , vol.16 , pp. 253-263
    • Li, C.1    Larson, D.2    Zhang, Z.3    Liu, Z.4
  • 12
    • 33750309227 scopus 로고    scopus 로고
    • Polymorphisms in the FAS and FASL genes and risk of lung cancer in a Korean population
    • Park SH, Choi JEm Kim EJ, et al. Polymorphisms in the FAS and FASL genes and risk of lung cancer in a Korean population. Lung Cancer. 2006;54:303-308.
    • (2006) Lung Cancer , vol.54 , pp. 303-308
    • Park, S.H.1    Choi, J.E.2    Kim, E.J.3
  • 13
    • 25844485937 scopus 로고    scopus 로고
    • FASL-844C polymorphism is associated with increased activation-induced T cell death and risk of cervical cancer
    • Sun T, Zhou Y, Li H, et al. FASL-844C polymorphism is associated with increased activation-induced T cell death and risk of cervical cancer. J Exp Med. 2005;202:967-974.
    • (2005) J Exp Med , vol.202 , pp. 967-974
    • Sun, T.1    Zhou, Y.2    Li, H.3
  • 14
    • 0035999095 scopus 로고    scopus 로고
    • Frequent downregulation of Fas (CD95) expression and function in melanoma: Frequent downregulation of Fas (CD95) expression and function in melanoma
    • Bullani RR, Wehrli P, Viard-Leveugle I. Frequent downregulation of Fas (CD95) expression and function in melanoma: frequent downregulation of Fas (CD95) expression and function in melanoma. Melanoma Res. 2002;12:263-270.
    • (2002) Melanoma Res , vol.12 , pp. 263-270
    • Bullani, R.R.1    Wehrli, P.2    Viard-Leveugle, I.3
  • 15
    • 0036379395 scopus 로고    scopus 로고
    • Regulation of Fas-mediated apoptosis by N-ras in melanoma
    • Urquhart JL, Meech SJ, Marr DG, et al. Regulation of Fas-mediated apoptosis by N-ras in melanoma. J Invest Dermatol. 2002;119:556-561.
    • (2002) J Invest Dermatol , vol.119 , pp. 556-561
    • Urquhart, J.L.1    Meech, S.J.2    Marr, D.G.3
  • 16
    • 27644509111 scopus 로고    scopus 로고
    • Experimental therapy using interferonγ and anti-Fas antibody against oral malignant melanoma cells
    • Kamei T, Inui M, Nakase M, et al. Experimental therapy using interferonγ and anti-Fas antibody against oral malignant melanoma cells. Melanoma Res. 2005;15:393-400.
    • (2005) Melanoma Res , vol.15 , pp. 393-400
    • Kamei, T.1    Inui, M.2    Nakase, M.3
  • 17
    • 4344653705 scopus 로고    scopus 로고
    • Essential role for hematopoietic Fas ligand (FasL) in the suppression of melanoma lung metastasis revealed in bone marrow chimeric mice
    • Hall CL, Yao M, Hill LL, et al. Essential role for hematopoietic Fas ligand (FasL) in the suppression of melanoma lung metastasis revealed in bone marrow chimeric mice. Clin Exp Metastasis. 2004;21:251-256.
    • (2004) Clin Exp Metastasis , vol.21 , pp. 251-256
    • Hall, C.L.1    Yao, M.2    Hill, L.L.3
  • 18
    • 0347948596 scopus 로고    scopus 로고
    • CD95/Fas signaling in human melanoma cells: Conditional expression of CD95L/FasL overcomes the intrinsic apoptosis resistance of malignant melanoma and inhibits growth and progression of human melanoma xenotransplants
    • Eberle J, Fecker LF, Hossini AM, et al. CD95/Fas signaling in human melanoma cells: conditional expression of CD95L/FasL overcomes the intrinsic apoptosis resistance of malignant melanoma and inhibits growth and progression of human melanoma xenotransplants. Oncogene. 2003;22:9131-9141.
    • (2003) Oncogene , vol.22 , pp. 9131-9141
    • Eberle, J.1    Fecker, L.F.2    Hossini, A.M.3
  • 19
    • 11944251186 scopus 로고    scopus 로고
    • Selective induction of apoptosis in melanoma cells by tyrosinase promoter-controlled CD95 ligand overexpression
    • Fecker LF, Geilen CC, Hossini AM, et al. Selective induction of apoptosis in melanoma cells by tyrosinase promoter-controlled CD95 ligand overexpression. J Invest Dermatol. 2005;124:221-228.
    • (2005) J Invest Dermatol , vol.124 , pp. 221-228
    • Fecker, L.F.1    Geilen, C.C.2    Hossini, A.M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.